Real-World Comparative Analysis of Liposomal Doxorubicin Versus Paclitaxel as First-Line Therapy for Kaposi Sarcoma
J Acquir Immune Defic Syndr
.
2025 Feb 1;98(2):e4-e6.
doi: 10.1097/QAI.0000000000003557.
Authors
Mariana Carvalho Gouveia
1
,
Heloisa Guedes Andrade
,
Cassio Murilo Hidalgo Filho
,
Marina Acevedo Zarzar de Melo
,
Mateus Zapparoli Claro
,
Arthur de Ávila Machado Modesto
,
Lucas Tadeu Barrak Stangler
,
Mirella Nardo
,
Alice Nayane Rosa Morais
,
Renata Colombo Bonadio
Affiliation
1
Instituto do Câncer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil.
PMID:
39497247
DOI:
10.1097/QAI.0000000000003557
No abstract available